GLP-2TZ [5MG]

$64.99

Available on backorder

Vials Discount
6 - 10 $61.74
11 - 15 $58.49
16 - 20 $55.24
21 + $51.99
Purchase & earn 65 points!

Dual GIP/GLP-1 Receptor Agonist | Metabolic & Glucose Regulation Research | USA Manufactured & Third-Party Tested

Tirzepatide is a synthetic peptide currently being investigated for its dual agonist action on glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual-target mechanism makes it a compound of high interest in metabolic, glycemic, and weight regulation research.

Each 5mg vial of Tirzepatide is provided as a lyophilized powder to ensure stability, accuracy, and usability in laboratory environments. Manufactured in a cGMP-certified U.S. facility and third-party tested for >99% purity, this research-grade compound supports advanced studies into insulin sensitivity, appetite signaling, energy balance, and endocrine function.

Key Features

  • 5mg lyophilized Tirzepatide per vial

  • Dual GIP and GLP-1 receptor agonist

  • USA-manufactured

  • Third-party tested for >99% purity and identity

  • Designed for research into metabolism, glucose homeostasis, and hormonal regulation

  • For research use only – not for human consumption

Disclaimer: This product is intended strictly for laboratory research purposes only. It is not a drug, food, or cosmetic, and is not for human use or consumption under any circumstances.

Shopping Cart